Use of aripiprazole during late pregnancy in a woman with psychotic illness [2]

Annals of Pharmacotherapy

Volumn 40, Issue 3, 2006, Pages 575-

  Mendhekar, D N ^a   Sharma, J B ^b   Srilakshmi, Pingali ^a  

^a G B PANT HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; DOPAMINE 2 RECEPTOR; SEROTONIN 1A RECEPTOR;

CIGARETTE SMOKING; DRUG USE; FETUS WEIGHT; HUMAN; LETTER; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; RISK ASSESSMENT; SYMPTOMATOLOGY; URINALYSIS;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS; QUINOLONES; SCHIZOPHRENIA, PARANOID;

EID: 33645053243     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G507     Document Type: Letter

References (5)

1. Liberman JA. Dopamine partial agonist: a new class of antipsychotic. CNS Drugs 2004;18:251-67.
2. Ernst CL, Goldberg JF. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry 2003;63(suppl 4):42-55.
3. Product information. Abilify (aripiprazole). Princeton, NJ: Bristol-Myers Squibb, August 2003.
4. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 2004;38:1265-71. Epub 18 May 2004. DOI 10.1345/aph.1D485
5. Nordeng H, Spigset O. [Use of antipsychotics during pregnancy and lactation] Norwegian. Tidsskr Nor Laegeforen 2003;123:2033-5.